Detalhe da pesquisa
1.
Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series.
J Transl Med
; 22(1): 150, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350968
2.
Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy.
Int J Mol Sci
; 23(5)2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35269844
3.
Splice variants of RAS-translational significance.
Cancer Metastasis Rev
; 39(4): 1039-1049, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772213
4.
Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma.
Acta Oncol
; 58(8): 1087-1094, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002007
5.
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
BMC Cancer
; 18(1): 598, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29801465
6.
[Molecular diagnostics of ALK-positive lung cancer]. / Az ALK-pozitív tüdõrák korszerû diagnosztikája.
Magy Onkol
; 61(3): 301-311, 2017 Sep 20.
Artigo
em Húngaro
| MEDLINE | ID: mdl-28931104
7.
[Melanoma research in Hungary: promising results in a previously orphan tumor]. / Hazai melanomakutatások: reményt keltõ eredmények egy korábban reménytelen daganatban.
Magy Onkol
; 59(4): 275-81, 2015 Dec.
Artigo
em Húngaro
| MEDLINE | ID: mdl-26665186
8.
[Prognostic and predictive markers of malignant melanoma]. / A malignus melanóma prognosztikus és prediktív markerei.
Magy Onkol
; 57(2): 79-83, 2013 Jun.
Artigo
em Húngaro
| MEDLINE | ID: mdl-23795352
9.
[Molecular epidemiology of microsatellite instability/mismatch repair deficiency in our institute - methodical aspects]. / A mikroszatellita-instabilitás/mismatch repair deficiencia genetikai hibák molekuláris epidemiológiája intézetünkben: módszertani megfontolások.
Magy Onkol
; 67(2): 147-153, 2023 Jun 13.
Artigo
em Húngaro
| MEDLINE | ID: mdl-37314076
10.
Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
Mol Cancer
; 11: 83, 2012 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23151220
11.
Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.
Int J Cancer
; 131(1): 95-105, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21858809
12.
Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging.
Anal Bioanal Chem
; 403(8): 2315-25, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22447214
13.
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers (Basel)
; 14(10)2022 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626010
14.
[Investigation of fatty acid profile for diagnostic purposes in mouse melanoma]. / A szérum zsírsavprofil diagnosztikus jelentõségének vizsgálata kísérletes modellben.
Magy Onkol
; 55(3): 199-204, 2011 Sep.
Artigo
em Húngaro
| MEDLINE | ID: mdl-21918746
15.
[Effect of KRAS mutation status on the efficiency of Avastin therapy of colorectal cancer]. / A kolorektális rákok KRAS-mutációs státuszának hatása az Avastin-terápia hatékonyságára.
Magy Onkol
; 55(2): 99-100, 102-4, 2011 Jun.
Artigo
em Húngaro
| MEDLINE | ID: mdl-21655475
16.
[EGFR protein is a negative prognostic and predictive factor in wild-type RAS colorectal cancer]. / Az EGFR-protein-expresszió negatív prognosztikus és prediktív marker vad RAS típusú vastagbélrákban.
Magy Onkol
; 65(2): 121-127, 2021 Jun 03.
Artigo
em Húngaro
| MEDLINE | ID: mdl-34081760
17.
EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas.
Pathol Oncol Res
; 27: 620256, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34257586
18.
[Predictive relevance of KRAS mutational status in bone metastatic lung adenocarcinoma treated with bisphosphonate therapy]. / A KRAS-mutációs státusz prediktív szerepe biszfoszfonáttal kezelt, csontáttétet képzo tüdo-adenokarcinómában.
Magy Onkol
; 65(2): 103-111, 2021 Jun 03.
Artigo
em Húngaro
| MEDLINE | ID: mdl-34081758
19.
[Consequences of extracellular alterations of EGFR on cetuximab therapy in HNSCC]. / Az EGFR extracelluláris módosulásainak hatása fej-nyaki daganatok cetuximabterápiájára.
Magy Onkol
; 65(2): 188-195, 2021 06 03.
Artigo
em Húngaro
| MEDLINE | ID: mdl-34081766
20.
The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation.
Transl Lung Cancer Res
; 10(2): 675-684, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718013